AI-driven estimation of O6 methylguanine-DNA-methyltransferase (MGMT) promoter methylation in glioblastoma patients: a systematic review with bias analysis
Mullapudi Venkata Sai Samartha(International Institute of Information Technology), Sanjay Saxena(PSG INSTITUTE OF TECHNOLOGY AND APPLIED RESEARCH)
Cited by 7
Related Papers
Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine
|Cancers|2022|121
Brain Tumor Characterization Using Radiogenomics in Artificial Intelligence Framework
|Cancers|2022|77
Recommender System for the Efficient Treatment of COVID-19 Using a Convolutional Neural Network Model and Image Similarity
|Diagnostics|2022|24
Prediction of O-6-methylguanine-DNA methyltransferase and overall survival of the patients suffering from glioblastoma using MRI-based hybrid radiomics signatures in machine and deep learning framework
|Neural Computing and Applications|2023|23
Contributors
|Elsevier eBooks|2024|0